MiR-214 regulates fracture healing through inhibiting Sox4 and its mechanism

Zhaoxu Xin1, Defu Cai2, Jingchun Wang3

  • 1Department of Orthopaedics, The Third Affiliated Hospital of Qiqihar Medical University, P.R. China.

Abstract

Insights

Micro ribonucleic acid (miR)-214 expression declines in patients with fragility fractures. This microRNA promotes osteoblast proliferation and bone healing by inhibiting Sox4, offering new therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Orthopedics

Background:

  • Fragility fractures represent a significant clinical challenge.
  • MicroRNAs (miRNAs) play crucial roles in cellular processes and disease.
  • Understanding the role of specific miRNAs in fracture healing is essential for developing novel treatments.

Purpose of the Study:

  • To investigate the expression levels of micro ribonucleic acid (miR)-214 in bone and blood samples from patients with fragility fractures.
  • To elucidate the functional role of miR-214 in osteoblast proliferation, apoptosis, and fracture healing.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to measure miR-214 expression.
  • Osteoblast proliferation was assessed using the MTT assay.
  • Apoptosis was evaluated via TUNEL staining.
  • Protein expression of BSP, BMP2, Sox4, PI3K, and AKT was analyzed.

Main Results:

  • miR-214 expression was significantly decreased in the bone tissue and blood of patients with fragility fractures.
  • miR-214 promoted osteoblast proliferation and inhibited apoptosis.
  • miR-214 enhanced the expression of bone sialoprotein (BSP) and bone morphogenetic protein 2 (BMP2).
  • miR-214 was shown to inhibit Sox4 expression and promote the phosphorylation of the PI3K/AKT pathway.

Conclusions:

  • miR-214 plays a critical role in regulating osteoblast function and fracture healing.
  • The findings suggest that miR-214 influences fracture healing by modulating osteoblast proliferation, apoptosis, and bone formation.
  • Targeting miR-214 presents a potential therapeutic strategy for improving fracture healing in patients with fragility fractures.